Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 20, 2019 at 06:16 am
Share
Frélii, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales were USD 16,943 compared to USD 450 a year ago. Operating loss was USD 346,797 compared to USD 826,383 a year ago. Net loss was USD 347,484 compared to USD 823,700 a year ago.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
FRÉLII, INC. 
